Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1628

Similar articles for PubMed (Select 17077242)

1.

Comparison of serum markers in first-trimester down syndrome screening.

Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium.

Obstet Gynecol. 2006 Nov;108(5):1192-9.

PMID:
17077242
2.

First trimester biochemical markers in twin pregnancies.

Celen S, Engin-Ustün Y, Türkçapar F, Aktulay A, Yilmaz N, Oksüzoğlu A, Yörük O, Danişman N.

Ginekol Pol. 2015 May;86(5):362-5.

PMID:
26117974
3.

Use of first or second trimester serum markers, or both, to predict preeclampsia.

Lambert-Messerlian G, Eklund EE, Chien EK, Rosene-Montella K, Neveux LM, Haddow HR, Palomaki GE.

Pregnancy Hypertens. 2014 Oct;4(4):271-8. doi: 10.1016/j.preghy.2014.07.001. Epub 2014 Jul 29.

PMID:
26104816
4.

Diagnostic value of ultrasonographic combining biochemical markers for Down syndrome screening in first trimester: a meta-analysis.

Liu Y, Ye X, Zhang N, Zhang B, Guo C, Huang W, Jing L, Wang M, Yang G, Wei X, Jing C.

Prenat Diagn. 2015 May 26. doi: 10.1002/pd.4626. [Epub ahead of print]

PMID:
26014106
5.

Predictive performance of a seven-plex antibody array in prenatal screening for Down Syndrome.

Pennings JL, Imholz S, Zutt I, Koster MP, Siljee JE, de Vries A, Schielen PC, Rodenburg W.

Dis Markers. 2015;2015:519851. doi: 10.1155/2015/519851. Epub 2015 Apr 23.

6.
7.

Evaluation of a semi-quantitative pregnancy device for susceptibility to interference caused by hCGβcf.

Nerenz RD, Butch AW, Ashby L, Woldemariam GA, Gronowski AM.

Clin Biochem. 2015 Apr 25. pii: S0009-9120(15)00139-3. doi: 10.1016/j.clinbiochem.2015.04.015. [Epub ahead of print]

PMID:
25916816
8.

The effect of maternal polycystic ovary morphology on first-trimester maternal serum biochemical markers of aneuploidy and fetal nuchal translucency thickness.

Hacivelioglu S, Uysal A, Gungor AN, Gencer M, Cakir DU, Cosar E.

Clin Exp Obstet Gynecol. 2015;42(1):32-5.

PMID:
25864278
9.

Serological prenatal screening and diagnosis for Down syndrome.

Duan Y, Li Y, Xue Q.

Clin Exp Obstet Gynecol. 2014;41(5):572-4.

PMID:
25864262
10.

Prenatal diagnosis of Down syndrome: study of correlations between two types of blood collection tubes.

Laudat A, Girard P, Burc-Struxiano L.

Ann Biol Clin (Paris). 2015 Jun 1;73(3):380-388.

PMID:
25858010
11.

First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-β human chorionic gonadotrophin, placental growth factor, and α-fetoprotein.

Huang T, Dennis A, Meschino WS, Rashid S, Mak-Tam E, Cuckle H.

Prenat Diagn. 2015 Jul;35(7):709-16. doi: 10.1002/pd.4597. Epub 2015 May 19.

PMID:
25846403
12.

Incorporation of dried blood alpha fetoprotein into traditional first trimester Down syndrome screening service.

Carmichael J, Krantz D, Liu HP, Janik D, Hallahan T.

Prenat Diagn. 2015 Jul;35(7):703-8. doi: 10.1002/pd.4596. Epub 2015 May 13.

PMID:
25846256
13.

Recurrent enlarged nuchal translucency: first trimester presentation of a familial 15q26→qter deletion.

Reiss R, Ahern D, Sandstrom M, Wilkins-Haug L.

Am J Med Genet A. 2015 Mar;167A(3):612-6. doi: 10.1002/ajmg.a.36913.

PMID:
25691414
14.

Dried blood spot measurement of pregnancy-associated plasma protein A (PAPP-A) and free β-subunit of human chorionic gonadotropin (β-hCG) from a low-resource setting.

Browne JL, Schielen PC, Belmouden I, Pennings JL, Klipstein-Grobusch K.

Prenat Diagn. 2015 Jun;35(6):592-7. doi: 10.1002/pd.4578. Epub 2015 Apr 1.

PMID:
25688936
15.

Changes in first trimester screening test parameters in pregnancies complicated by placenta previa and association with hyperemesis gravidarum.

Tülek F, Kahraman A, Taşkın S, Özkavukçu E, Söylemez F.

J Turk Ger Gynecol Assoc. 2014 Dec 1;15(4):212-6. doi: 10.5152/jtgga.2014.14045. eCollection 2014.

16.
17.

Early-onset severe preeclampsia by first trimester pregnancy-associated plasma protein a and total human chorionic gonadotropin.

Jelliffe-Pawlowski LL, Baer RJ, Currier RJ, Lyell DJ, Blumenfeld YJ, El-Sayed YY, Shaw GM, Druzin ML.

Am J Perinatol. 2015 Jun;32(7):703-12. doi: 10.1055/s-0034-1396697. Epub 2014 Dec 17.

PMID:
25519199
18.

First-trimester combined screening for trisomy 21 in women with renal disease.

Valentin M, Muller F, Beaujard MP, Dreux S, Czerkiewicz I, Meyer V, Leruez M, Ville Y, Salomon LJ.

Prenat Diagn. 2015 Mar;35(3):244-8. doi: 10.1002/pd.4528. Epub 2015 Feb 2.

PMID:
25395363
19.

First-trimester aneuploidy screening: is there a maternal age at which it loses effectiveness?

Lau GW, Feldman DS, Morales CM, Smith D, Edwards R, Williams J 3rd.

J Reprod Med. 2014 Sep-Oct;59(9-10):443-7.

PMID:
25330685
20.

Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies.

Evans MI, Sonek JD, Hallahan TW, Krantz DA.

Ultrasound Obstet Gynecol. 2015 Jan;45(1):74-83. doi: 10.1002/uog.14693. Epub 2014 Dec 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk